Pilot Project Renal and Cardiovascular Tertiary Prevention in Preeclampsia

University Hospital Schleswig-Holstein100 enrolled

Overview

Tertiary prevention program for women with preeclampsia, HELLP syndrome, kidney disease and pregnancy or associated conditions, including founding of a biobank. (Observational study since no interference with regular path of treatment suggested in national and international guidelines)

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Preeclampsia HELLP Syndrome Eclampsia Kidney Disease

Eligibility

Sex: FEMALEMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * older than 18 yrs * diagnosed preeclampsia, HELLP syndrome or kidney disease durig pregnancy Exclusion Criteria: * unable for informed consent

Locations (1)

University Hospital Schleswig- Holstein

Kiel, Germany

RECRUITING

Outcomes

Primary Outcomes

Pulse wave velocity

Time frame: 12 months

Central Contacts

Laura K Sievers, MD

CONTACT

+49 431 500 23001 Laura.Rakow@uksh.de

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.